Sex;Age group;Size of municipality of residence;Perception of risk of infection of HIV/AIDS by injectable drugs;Total
Both sexes;Total;Total;Total;100.00
Both sexes;Total;Total;High risk;59.10
Both sexes;Total;Total;Intermediate risk;9.96
Both sexes;Total;Total;Low or no risk;0.47
Both sexes;Total;Total;Depends on whether they share syringes or not;30.47
Both sexes;Total;Up to 10000 inhabitants;Total;100.00
Both sexes;Total;Up to 10000 inhabitants;High risk;59.23
Both sexes;Total;Up to 10000 inhabitants;Intermediate risk;10.14
Both sexes;Total;Up to 10000 inhabitants;Low or no risk;0.65
Both sexes;Total;Up to 10000 inhabitants;Depends on whether they share syringes or not;29.99
Both sexes;Total;From 10001 to 50000 inhabitants;Total;100.00
Both sexes;Total;From 10001 to 50000 inhabitants;High risk;58.85
Both sexes;Total;From 10001 to 50000 inhabitants;Intermediate risk;9.80
Both sexes;Total;From 10001 to 50000 inhabitants;Low or no risk;0.35
Both sexes;Total;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;31.00
Both sexes;Total;From 50001 to 500000 inhabitants;Total;100.00
Both sexes;Total;From 50001 to 500000 inhabitants;High risk;59.58
Both sexes;Total;From 50001 to 500000 inhabitants;Intermediate risk;10.08
Both sexes;Total;From 50001 to 500000 inhabitants;Low or no risk;0.49
Both sexes;Total;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;29.85
Both sexes;Total;More than 500000 inhabitants;Total;100.00
Both sexes;Total;More than 500000 inhabitants;High risk;58.32
Both sexes;Total;More than 500000 inhabitants;Intermediate risk;9.71
Both sexes;Total;More than 500000 inhabitants;Low or no risk;0.39
Both sexes;Total;More than 500000 inhabitants;Depends on whether they share syringes or not;31.58
Both sexes;From 18 to 29 years of age;Total;Total;100.00
Both sexes;From 18 to 29 years of age;Total;High risk;59.19
Both sexes;From 18 to 29 years of age;Total;Intermediate risk;11.07
Both sexes;From 18 to 29 years of age;Total;Low or no risk;0.50
Both sexes;From 18 to 29 years of age;Total;Depends on whether they share syringes or not;29.24
Both sexes;From 18 to 29 years of age;Up to 10000 inhabitants;Total;100.00
Both sexes;From 18 to 29 years of age;Up to 10000 inhabitants;High risk;59.01
Both sexes;From 18 to 29 years of age;Up to 10000 inhabitants;Intermediate risk;9.82
Both sexes;From 18 to 29 years of age;Up to 10000 inhabitants;Low or no risk;0.63
Both sexes;From 18 to 29 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;30.53
Both sexes;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Total;100.00
Both sexes;From 18 to 29 years of age;From 10001 to 50000 inhabitants;High risk;59.49
Both sexes;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Intermediate risk;10.99
Both sexes;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Low or no risk;0.19
Both sexes;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;29.33
Both sexes;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Total;100.00
Both sexes;From 18 to 29 years of age;From 50001 to 500000 inhabitants;High risk;59.90
Both sexes;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Intermediate risk;11.50
Both sexes;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Low or no risk;0.60
Both sexes;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;27.99
Both sexes;From 18 to 29 years of age;More than 500000 inhabitants;Total;100.00
Both sexes;From 18 to 29 years of age;More than 500000 inhabitants;High risk;57.45
Both sexes;From 18 to 29 years of age;More than 500000 inhabitants;Intermediate risk;11.82
Both sexes;From 18 to 29 years of age;More than 500000 inhabitants;Low or no risk;0.59
Both sexes;From 18 to 29 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;30.14
Both sexes;From 30 to 39 years of age;Total;Total;100.00
Both sexes;From 30 to 39 years of age;Total;High risk;57.06
Both sexes;From 30 to 39 years of age;Total;Intermediate risk;9.68
Both sexes;From 30 to 39 years of age;Total;Low or no risk;0.46
Both sexes;From 30 to 39 years of age;Total;Depends on whether they share syringes or not;32.81
Both sexes;From 30 to 39 years of age;Up to 10000 inhabitants;Total;100.00
Both sexes;From 30 to 39 years of age;Up to 10000 inhabitants;High risk;57.59
Both sexes;From 30 to 39 years of age;Up to 10000 inhabitants;Intermediate risk;10.34
Both sexes;From 30 to 39 years of age;Up to 10000 inhabitants;Low or no risk;0.37
Both sexes;From 30 to 39 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;31.70
Both sexes;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Total;100.00
Both sexes;From 30 to 39 years of age;From 10001 to 50000 inhabitants;High risk;56.08
Both sexes;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Intermediate risk;9.21
Both sexes;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Low or no risk;0.47
Both sexes;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;34.25
Both sexes;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Total;100.00
Both sexes;From 30 to 39 years of age;From 50001 to 500000 inhabitants;High risk;57.17
Both sexes;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Intermediate risk;9.95
Both sexes;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Low or no risk;0.63
Both sexes;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;32.25
Both sexes;From 30 to 39 years of age;More than 500000 inhabitants;Total;100.00
Both sexes;From 30 to 39 years of age;More than 500000 inhabitants;High risk;57.54
Both sexes;From 30 to 39 years of age;More than 500000 inhabitants;Intermediate risk;8.94
Both sexes;From 30 to 39 years of age;More than 500000 inhabitants;Low or no risk;0.24
Both sexes;From 30 to 39 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;33.28
Both sexes;From 40 to 49 years of age;Total;Total;100.00
Both sexes;From 40 to 49 years of age;Total;High risk;61.37
Both sexes;From 40 to 49 years of age;Total;Intermediate risk;8.87
Both sexes;From 40 to 49 years of age;Total;Low or no risk;0.45
Both sexes;From 40 to 49 years of age;Total;Depends on whether they share syringes or not;29.31
Both sexes;From 40 to 49 years of age;Up to 10000 inhabitants;Total;100.00
Both sexes;From 40 to 49 years of age;Up to 10000 inhabitants;High risk;61.37
Both sexes;From 40 to 49 years of age;Up to 10000 inhabitants;Intermediate risk;10.27
Both sexes;From 40 to 49 years of age;Up to 10000 inhabitants;Low or no risk;0.98
Both sexes;From 40 to 49 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;27.38
Both sexes;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Total;100.00
Both sexes;From 40 to 49 years of age;From 10001 to 50000 inhabitants;High risk;61.37
Both sexes;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Intermediate risk;8.92
Both sexes;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Low or no risk;0.44
Both sexes;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;29.27
Both sexes;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Total;100.00
Both sexes;From 40 to 49 years of age;From 50001 to 500000 inhabitants;High risk;61.87
Both sexes;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Intermediate risk;8.38
Both sexes;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Low or no risk;0.17
Both sexes;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;29.58
Both sexes;From 40 to 49 years of age;More than 500000 inhabitants;Total;100.00
Both sexes;From 40 to 49 years of age;More than 500000 inhabitants;High risk;60.37
Both sexes;From 40 to 49 years of age;More than 500000 inhabitants;Intermediate risk;7.93
Both sexes;From 40 to 49 years of age;More than 500000 inhabitants;Low or no risk;0.31
Both sexes;From 40 to 49 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;31.38
Males;Total;Total;Total;100.00
Males;Total;Total;High risk;59.30
Males;Total;Total;Intermediate risk;11.71
Males;Total;Total;Low or no risk;0.68
Males;Total;Total;Depends on whether they share syringes or not;28.30
Males;Total;Up to 10000 inhabitants;Total;100.00
Males;Total;Up to 10000 inhabitants;High risk;59.21
Males;Total;Up to 10000 inhabitants;Intermediate risk;11.91
Males;Total;Up to 10000 inhabitants;Low or no risk;0.82
Males;Total;Up to 10000 inhabitants;Depends on whether they share syringes or not;28.07
Males;Total;From 10001 to 50000 inhabitants;Total;100.00
Males;Total;From 10001 to 50000 inhabitants;High risk;58.39
Males;Total;From 10001 to 50000 inhabitants;Intermediate risk;12.20
Males;Total;From 10001 to 50000 inhabitants;Low or no risk;0.54
Males;Total;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;28.87
Males;Total;From 50001 to 500000 inhabitants;Total;100.00
Males;Total;From 50001 to 500000 inhabitants;High risk;61.24
Males;Total;From 50001 to 500000 inhabitants;Intermediate risk;11.69
Males;Total;From 50001 to 500000 inhabitants;Low or no risk;0.63
Males;Total;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;26.44
Males;Total;More than 500000 inhabitants;Total;100.00
Males;Total;More than 500000 inhabitants;High risk;56.71
Males;Total;More than 500000 inhabitants;Intermediate risk;10.74
Males;Total;More than 500000 inhabitants;Low or no risk;0.81
Males;Total;More than 500000 inhabitants;Depends on whether they share syringes or not;31.74
Males;From 18 to 29 years of age;Total;Total;100.00
Males;From 18 to 29 years of age;Total;High risk;59.03
Males;From 18 to 29 years of age;Total;Intermediate risk;12.55
Males;From 18 to 29 years of age;Total;Low or no risk;0.79
Males;From 18 to 29 years of age;Total;Depends on whether they share syringes or not;27.63
Males;From 18 to 29 years of age;Up to 10000 inhabitants;Total;100.00
Males;From 18 to 29 years of age;Up to 10000 inhabitants;High risk;55.95
Males;From 18 to 29 years of age;Up to 10000 inhabitants;Intermediate risk;12.32
Males;From 18 to 29 years of age;Up to 10000 inhabitants;Low or no risk;0.78
Males;From 18 to 29 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;30.95
Males;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Total;100.00
Males;From 18 to 29 years of age;From 10001 to 50000 inhabitants;High risk;59.38
Males;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Intermediate risk;13.17
Males;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Low or no risk;0.28
Males;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;27.17
Males;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Total;100.00
Males;From 18 to 29 years of age;From 50001 to 500000 inhabitants;High risk;62.12
Males;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Intermediate risk;12.29
Males;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Low or no risk;0.99
Males;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;24.60
Males;From 18 to 29 years of age;More than 500000 inhabitants;Total;100.00
Males;From 18 to 29 years of age;More than 500000 inhabitants;High risk;55.38
Males;From 18 to 29 years of age;More than 500000 inhabitants;Intermediate risk;12.39
Males;From 18 to 29 years of age;More than 500000 inhabitants;Low or no risk;1.18
Males;From 18 to 29 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;31.04
Males;From 30 to 39 years of age;Total;Total;100.00
Males;From 30 to 39 years of age;Total;High risk;57.81
Males;From 30 to 39 years of age;Total;Intermediate risk;11.21
Males;From 30 to 39 years of age;Total;Low or no risk;0.60
Males;From 30 to 39 years of age;Total;Depends on whether they share syringes or not;30.38
Males;From 30 to 39 years of age;Up to 10000 inhabitants;Total;100.00
Males;From 30 to 39 years of age;Up to 10000 inhabitants;High risk;57.81
Males;From 30 to 39 years of age;Up to 10000 inhabitants;Intermediate risk;11.73
Males;From 30 to 39 years of age;Up to 10000 inhabitants;Low or no risk;0.71
Males;From 30 to 39 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;29.75
Males;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Total;100.00
Males;From 30 to 39 years of age;From 10001 to 50000 inhabitants;High risk;56.62
Males;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Intermediate risk;11.53
Males;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Low or no risk;0.57
Males;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;31.29
Males;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Total;100.00
Males;From 30 to 39 years of age;From 50001 to 500000 inhabitants;High risk;59.22
Males;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Intermediate risk;11.42
Males;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Low or no risk;0.59
Males;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;28.77
Males;From 30 to 39 years of age;More than 500000 inhabitants;Total;100.00
Males;From 30 to 39 years of age;More than 500000 inhabitants;High risk;56.64
Males;From 30 to 39 years of age;More than 500000 inhabitants;Intermediate risk;9.51
Males;From 30 to 39 years of age;More than 500000 inhabitants;Low or no risk;0.51
Males;From 30 to 39 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;33.34
Males;From 40 to 49 years of age;Total;Total;100.00
Males;From 40 to 49 years of age;Total;High risk;61.45
Males;From 40 to 49 years of age;Total;Intermediate risk;11.21
Males;From 40 to 49 years of age;Total;Low or no risk;0.63
Males;From 40 to 49 years of age;Total;Depends on whether they share syringes or not;26.71
Males;From 40 to 49 years of age;Up to 10000 inhabitants;Total;100.00
Males;From 40 to 49 years of age;Up to 10000 inhabitants;High risk;64.09
Males;From 40 to 49 years of age;Up to 10000 inhabitants;Intermediate risk;11.67
Males;From 40 to 49 years of age;Up to 10000 inhabitants;Low or no risk;0.97
Males;From 40 to 49 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;23.27
Males;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Total;100.00
Males;From 40 to 49 years of age;From 10001 to 50000 inhabitants;High risk;59.19
Males;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Intermediate risk;11.62
Males;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Low or no risk;0.89
Males;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;28.30
Males;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Total;100.00
Males;From 40 to 49 years of age;From 50001 to 500000 inhabitants;High risk;62.43
Males;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Intermediate risk;11.20
Males;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Low or no risk;0.18
Males;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;26.19
Males;From 40 to 49 years of age;More than 500000 inhabitants;Total;100.00
Males;From 40 to 49 years of age;More than 500000 inhabitants;High risk;58.54
Males;From 40 to 49 years of age;More than 500000 inhabitants;Intermediate risk;9.98
Males;From 40 to 49 years of age;More than 500000 inhabitants;Low or no risk;0.65
Males;From 40 to 49 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;30.82
Females;Total;Total;Total;100.00
Females;Total;Total;High risk;58.89
Females;Total;Total;Intermediate risk;8.16
Females;Total;Total;Low or no risk;0.26
Females;Total;Total;Depends on whether they share syringes or not;32.69
Females;Total;Up to 10000 inhabitants;Total;100.00
Females;Total;Up to 10000 inhabitants;High risk;59.24
Females;Total;Up to 10000 inhabitants;Intermediate risk;8.27
Females;Total;Up to 10000 inhabitants;Low or no risk;0.47
Females;Total;Up to 10000 inhabitants;Depends on whether they share syringes or not;32.02
Females;Total;From 10001 to 50000 inhabitants;Total;100.00
Females;Total;From 10001 to 50000 inhabitants;High risk;59.34
Females;Total;From 10001 to 50000 inhabitants;Intermediate risk;7.24
Females;Total;From 10001 to 50000 inhabitants;Low or no risk;0.15
Females;Total;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;33.27
Females;Total;From 50001 to 500000 inhabitants;Total;100.00
Females;Total;From 50001 to 500000 inhabitants;High risk;57.86
Females;Total;From 50001 to 500000 inhabitants;Intermediate risk;8.42
Females;Total;From 50001 to 500000 inhabitants;Low or no risk;0.34
Females;Total;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;33.38
Females;Total;More than 500000 inhabitants;Total;100.00
Females;Total;More than 500000 inhabitants;High risk;59.82
Females;Total;More than 500000 inhabitants;Intermediate risk;8.75
Females;Total;More than 500000 inhabitants;Low or no risk;0.00
Females;Total;More than 500000 inhabitants;Depends on whether they share syringes or not;31.43
Females;From 18 to 29 years of age;Total;Total;100.00
Females;From 18 to 29 years of age;Total;High risk;59.35
Females;From 18 to 29 years of age;Total;Intermediate risk;9.53
Females;From 18 to 29 years of age;Total;Low or no risk;0.20
Females;From 18 to 29 years of age;Total;Depends on whether they share syringes or not;30.92
Females;From 18 to 29 years of age;Up to 10000 inhabitants;Total;100.00
Females;From 18 to 29 years of age;Up to 10000 inhabitants;High risk;61.83
Females;From 18 to 29 years of age;Up to 10000 inhabitants;Intermediate risk;7.52
Females;From 18 to 29 years of age;Up to 10000 inhabitants;Low or no risk;0.50
Females;From 18 to 29 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;30.15
Females;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Total;100.00
Females;From 18 to 29 years of age;From 10001 to 50000 inhabitants;High risk;59.62
Females;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Intermediate risk;8.44
Females;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Low or no risk;0.08
Females;From 18 to 29 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;31.86
Females;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Total;100.00
Females;From 18 to 29 years of age;From 50001 to 500000 inhabitants;High risk;57.54
Females;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Intermediate risk;10.66
Females;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Low or no risk;0.19
Females;From 18 to 29 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;31.62
Females;From 18 to 29 years of age;More than 500000 inhabitants;Total;100.00
Females;From 18 to 29 years of age;More than 500000 inhabitants;High risk;59.50
Females;From 18 to 29 years of age;More than 500000 inhabitants;Intermediate risk;11.24
Females;From 18 to 29 years of age;More than 500000 inhabitants;Low or no risk;0.00
Females;From 18 to 29 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;29.25
Females;From 30 to 39 years of age;Total;Total;100.00
Females;From 30 to 39 years of age;Total;High risk;56.28
Females;From 30 to 39 years of age;Total;Intermediate risk;8.09
Females;From 30 to 39 years of age;Total;Low or no risk;0.32
Females;From 30 to 39 years of age;Total;Depends on whether they share syringes or not;35.32
Females;From 30 to 39 years of age;Up to 10000 inhabitants;Total;100.00
Females;From 30 to 39 years of age;Up to 10000 inhabitants;High risk;57.35
Females;From 30 to 39 years of age;Up to 10000 inhabitants;Intermediate risk;8.82
Females;From 30 to 39 years of age;Up to 10000 inhabitants;Low or no risk;0.00
Females;From 30 to 39 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;33.83
Females;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Total;100.00
Females;From 30 to 39 years of age;From 10001 to 50000 inhabitants;High risk;55.51
Females;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Intermediate risk;6.75
Females;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Low or no risk;0.36
Females;From 30 to 39 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;37.38
Females;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Total;100.00
Females;From 30 to 39 years of age;From 50001 to 500000 inhabitants;High risk;54.95
Females;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Intermediate risk;8.37
Females;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Low or no risk;0.68
Females;From 30 to 39 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;35.99
Females;From 30 to 39 years of age;More than 500000 inhabitants;Total;100.00
Females;From 30 to 39 years of age;More than 500000 inhabitants;High risk;58.31
Females;From 30 to 39 years of age;More than 500000 inhabitants;Intermediate risk;8.46
Females;From 30 to 39 years of age;More than 500000 inhabitants;Low or no risk;0.00
Females;From 30 to 39 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;33.23
Females;From 40 to 49 years of age;Total;Total;100.00
Females;From 40 to 49 years of age;Total;High risk;61.30
Females;From 40 to 49 years of age;Total;Intermediate risk;6.54
Females;From 40 to 49 years of age;Total;Low or no risk;0.27
Females;From 40 to 49 years of age;Total;Depends on whether they share syringes or not;31.89
Females;From 40 to 49 years of age;Up to 10000 inhabitants;Total;100.00
Females;From 40 to 49 years of age;Up to 10000 inhabitants;High risk;58.13
Females;From 40 to 49 years of age;Up to 10000 inhabitants;Intermediate risk;8.60
Females;From 40 to 49 years of age;Up to 10000 inhabitants;Low or no risk;0.99
Females;From 40 to 49 years of age;Up to 10000 inhabitants;Depends on whether they share syringes or not;32.28
Females;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Total;100.00
Females;From 40 to 49 years of age;From 10001 to 50000 inhabitants;High risk;63.45
Females;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Intermediate risk;6.35
Females;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Low or no risk;0.00
Females;From 40 to 49 years of age;From 10001 to 50000 inhabitants;Depends on whether they share syringes or not;30.20
Females;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Total;100.00
Females;From 40 to 49 years of age;From 50001 to 500000 inhabitants;High risk;61.33
Females;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Intermediate risk;5.73
Females;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Low or no risk;0.16
Females;From 40 to 49 years of age;From 50001 to 500000 inhabitants;Depends on whether they share syringes or not;32.79
Females;From 40 to 49 years of age;More than 500000 inhabitants;Total;100.00
Females;From 40 to 49 years of age;More than 500000 inhabitants;High risk;62.06
Females;From 40 to 49 years of age;More than 500000 inhabitants;Intermediate risk;6.04
Females;From 40 to 49 years of age;More than 500000 inhabitants;Low or no risk;0.00
Females;From 40 to 49 years of age;More than 500000 inhabitants;Depends on whether they share syringes or not;31.90